A new study published in Nature says air pollution may be driving lung cancer development in people who have little to no ...

Precision oncology has entered a new phase, as data sets mature and a new wave of tools emerges to help clinicians manage ...

Lung cancer cases are on the rise in non-smokers around the world, and air pollution could be an insidious, contributing ...

A new international study, published in Nature, offers groundbreaking evidence that environmental exposures—particularly air ...

Learning I carried the BRCA1 mutation was terrifying, but it gave me the power to choose prevention, embrace survivorship, ...

Researchers working on an incurable blood cancer can now use a new lab model which could make testing potential new ...

Four days ahead of its July 7 PDUFA date, the U.S. FDA granted accelerated approval to Dizal (Jiangsu) Pharmaceutical Co. Ltd.’s sunvozertinib (DZD-9008), branded as Zegfrovy, for treating adults with ...

Scientists with the NIH-backed SMaHT Network are mapping every DNA mutation in the human body, creating a groundbreaking ...

Researchers working on an incurable blood cancer can now use a new lab model that could make testing potential new treatments and diagnostics easier and quicker, new research has found.

New research from UC Davis Comprehensive Cancer Center has uncovered an evolutionary change that may explain why certain ...

NEW YORK – The US Food and Drug Administration on Wednesday granted accelerated approval to Dizal's oral EGFR inhibitor Zegfrovy (sunvozertinib) as a treatment for patients with locally advanced or ...